KE Select, a leading scientific and medical recruitment agency, has entered into partnership with Southern RNA, a ground-breaking biomanufacturing organisation, to source and select exceptional technical talent to further their research into mRNA technology and nucleic acid manufacturing.
“We’re thrilled to be working with Southern RNA and look forward to helping them find and recruit scientists who will work synergistically with their already excellent team to deliver innovative and effective solutions for their customers,” said Kerry McMahon, CEO of KE Select.
![MRNA](https://thegreaterspringfieldtimes.com.au/wp-content/uploads/sites/5/2024/04/pexels-pixabay-356040-1024x683.jpg)
People are key to capitalise on the biomanufacturing boom.
Over the past decade, Australia has become a global contender in the biomanufacturing landscape, contributing to lifesaving therapeutics, impacting global health.
Our extraordinary research and clinical trial capabilities, coupled with streamlined and globally recognised regulatory pathways that expedite research from bench to bedside, have attracted unprecedented levels of funding from Government and the private sector.
For companies, such as Southern RNA, to capitalise on this boom in the industry, it’s vital that they hire the right people – scientists who will elevate their research, products, and services to even greater heights, satisfying their customers and attracting greater investment.
“Infrastructure and funding are important, of course,” said Kerry.
“But finding the right people is really the key to ensure that your company is ready to deliver the high standards of innovation, productivity and quality that today’s biomanufacturing industry demands.”
The team at KE Select is deeply engaged in the Australian Biomanufacturing space and, therefore, able to draw on an extensive network of contacts, spanning Australia, New Zealand, and the rest of the world, to source top-tier talent to fill positions at every level within Southern RNA.
“For more than 12 years, we’ve helped companies in the biomanufacturing sector find the right people. So, we know just how crucial it is to employ the right candidates to fill positions at all levels of the organisation,” Kerry adds.
Getting the right mix of experience and fresh ideas is paramount.
“Positioned as it is in the heart of Australia’s research sector, it is crucial for Southern RNA to attract and employ the right mix of scientists and technical staff, including both seasoned professionals and university graduates,” Kerry explains.
“University and TAFE graduates bring fresh ideas and knowledge of the latest innovations, while more experienced scientists draw on wisdom and insights gained over years at the coalface. These individuals are invaluable as they provide the training and leadership necessary for younger members of staff to thrive.”
The science and medical recruitment agents at KE Select will assist Southern RNA with identifying the skill sets and levels of experience required for each role.
They will then cast the net far and wide to yield a selection of high-calibre candidates from which Southern RNA will build a strong team to drive growth in this lucrative industry.
Southern RNA set to benefit from partnering with a science recruitment specialist.
“Our partnership with Southern RNA, like all our partnerships, goes beyond merely filling vacancies,” said Kerry.
“We form long-term relationships with our clients as this gives us an in-depth understanding of how the organisation functions and greater insight into the company ethos. This allows us to screen candidates for expertise and personality traits that will work best within the team. We also keep an eye out for subtle shifts in the industry and the impact these will have on our client’s needs, so we can work proactively with the client to ensure seamless transitions as people leave and join the company.”
This partnership shows Southern RNA’s firm commitment to hiring the best possible candidates who will further their already impressive molecular engineering, microbial cell bank production, Plasmid DNA production (linear and supercoiled), and mRNA production services.